13 active not recruiting. 13 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 13 | Active not recruiting 13 |
Follow Arthritis: new trials by email Literature Review of Arthritis trials Research Report on Arthritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Preoperative Correction of Vitamin D Deficiency in Total Joint Arthroplasty (TJA) Vitamin D3 - Osteoarthritis, Vitamin D Deficiency | Phase 4 | Active not recruiting | University of Miami | 200 | 2025-09-08 | 2026-09-23 |
| Application of Autologous Stem Cells From Adipose Tissue in the Regeneration of Knee Joint Cartilage stromal vascular fraction (SVF), CP - Osteearthritis | Phase 4 | Active not recruiting | Clinical Center of Vojvodina | 60 | 2025-06-25 | 2026-02-12 |
| A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA) Tirzepatide - Psoriatic Arthritis, Overweight or Obesity | Phase 4 | Active not recruiting | Eli Lilly and Company | 200 | 2025-03-06 | 2026-09-21 |
| Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA) Tirzepatide, Placebo - Obesity, Knee Osteoarthritis | Phase 4 | Active not recruiting | University of Melbourne | 352 | 2024-11-19 | 2026-10-13 |
| Effect of Proactive Therapeutic Drug Monitoring on Maintenance of Sustained Disease Control in Adults With Rheumatoid Arthritis on a Subcutaneous TNF Inhibitor: The Rheumatoid Arthritis Therapeutic DRUg Monitoring Trial (RA-DRUM) Therapeutic drug monitoring (TDM) of adalimumab - Rheumatoid Arthritis | Phase 4 | Active not recruiting | Diakonhjemmet Hospital | 387 | 2024-08-20 | 2026-07-01 |
| Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases Recombinant Herpes Zoster Vaccine (RZV), MTX Discontinuation, MMF Discontinuation - Rheumatoid Arthritis, Spondylitis, Ankylosing | Phase 4 | Active not recruiting | University of Sao Paulo General Hospital | 2005 | 2023-05-23 | 2026-05-04 |
| A Study of Secukinumab to Evaluate Maintenance of Response in Participants With Non-radiographic Axial Spondyloarthritis Who Achieved Remission Secukinumab, Placebo - Non-radiographic Axial Spondyloarthritis | Phase 4 | Active not recruiting | Novartis Pharmaceuticals | 240 | 2023-03-28 | 2026-10-14 |
| Study of Nonsteroidal Anti-inflammatory Drugs in People With Painful Knee Osteoarthritis Naproxen 500 Mg, Placebo - Osteoarthritis, Knee | Phase 4 | Active not recruiting | Northwestern University | 20 | 2022-08-24 | 2026-03-23 |
| Methotrexate in Patients with Early Rheumatoid Arthritis Methotrexate - Rheumatoid Arthritis | Phase 4 | Active not recruiting | Region Västerbotten | 212 | 2022-04-28 | 2025-01-14 |
| A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease Guselkumab, Placebo - Arthritis, Psoriatic | Phase 4 | Active not recruiting | Janssen Research & Development, LLC | 411 | 2021-08-30 | 2026-09-25 |
| Corticosteroid Meniscectomy Randomized Trial Zilretta Injectable Product or Placebo - Osteoarthritis, Knee, Meniscus Tear | Phase 4 | Active not recruiting | The Cleveland Clinic | 150 | 2021-05-27 | 2026-08-31 |
| The Impact of Procedural Awareness of Knee Injections for Osteoarthritis on Patient Perceptions of Effectiveness Platelet-rich plasma (PRP), Viewing of preparation - Osteoarthritis, Knee | Phase 4 | Active not recruiting | ArthroBiologix Inc. | 158 | 2019-10-01 | 2025-09-30 |
| Intravenous (IV) Hydrocortisone for TKA (Total Knee Arthroplasty) Hydrocortisone, Dextrose 5% in water (D5W) - Pain, Arthrofibrosis | Phase 4 | Active not recruiting | Hospital for Special Surgery, New York | 65 | 2019-07-24 | 2026-10-13 |
Osteoarthritis, Knee (5) · Osteoarthritis (4) · Arthritis, Rheumatoid (3) · Arthritis, Psoriatic (2) · Obesity (2) · Arthritis, Juvenile (1) · Behcet Syndrome (1) · Dermatomyositis (1) · Herpes Zoster (1) · Lupus Erythematosus, Systemic (1) · Myositis (1) · Non-Radiographic Axial Spondyloarthritis (1) · Overweight (1) · Pain (1) · Patient Preference (1)
Joint Diseases (13) · Musculoskeletal Diseases (13) · Rheumatic Diseases (10) · Skin and Connective Tissue Diseases (5) · Bone Diseases (4) · Spinal Diseases (4) · Spondylarthropathies (4) · Spondylitis (4) · Autoimmune Diseases (3) · Connective Tissue Diseases (3) · Immune System Diseases (3) · Nutrition Disorders (3) · Nutritional and Metabolic Diseases (3) · Osteoarthritis (3)
Tirzepatide (2) · Adalimumab (1) · Cholecalciferol (1) · Glucose (1) · Hydrocortisone (1) · Methotrexate (1) · Naproxen (1) · Triamcinolone Acetonide (1) · Water (1) · guselkumab (1) · secukinumab (1)
ArthroBiologix Inc. (1) · Clinical Center of Vojvodina (1) · Diakonhjemmet Hospital (1) · Eli Lilly and Company (1) · Hospital for Special Surgery, New York (1) · Janssen Research & Development, LLC (1) · Northwestern University (1) · Novartis Pharmaceuticals (1) · Region Västerbotten (1) · The Cleveland Clinic (1) · University of Melbourne (1) · University of Miami (1) · University of Sao Paulo General Hospital (1)
United States (6) · Italy (3) · Sweden (3) · Australia (2) · Brazil (2) · Canada (2) · Czechia (2) · Germany (2) · Hungary (2) · Israel (2) · Malaysia (2) · Philippines (2) · Poland (2) · Romania (2) · Thailand (2)
Espen A Haavardsholm, Phd, MD (1) · Michele D'Apuzzo, MD (1) · Michelle M Dowsey (1) · Moin Khan, FRCSC (1) · Morgan Jones, MD, MPH (1) · Thomas J Schnitzer, MD, PhD (1)
PMID 36064592, PMID 39572047, PMID 40992788, PMID 41679320, PMID 41932224, PMID 42261247, PMID 42294825, PMID 42843284
2023 (2)